Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.37 |
| ▸ | NPY1R | P25929 | 6/20 | 0.37 |
| ▸ | NPY2R | P49146 | 5/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.37 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | TACR3 | P29371 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7346009 | 0.99 | NPY4R (0.37) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| Trifluoroacetic Acid SCHEMBL9614816 | 0.95 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL7306013 | 0.85 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL30797917 | 0.85 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL7436345 | 0.85 | SMN1; SMN2 (0.36) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL29598552 | 0.84 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL7439764 | 0.84 | EPHX2 (0.36) | NPY4RNPY1RNPY2RNPY5RITGB3 | |
| SCHEMBL29407224 | 0.81 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| Trifluoroacetic Acid SCHEMBL7437664 | 0.80 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RENPEP | |
| SCHEMBL7441948 | 0.80 | EPHX2 (0.44) | NPY4RNPY1RNPY2RNPY5RITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494248-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | — | 1992-08-26 | — | — | EP | claimed |
| EP-0494248-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-07-15 | — | — | EP | claimed |
| WO-1991004746-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-04-18 | — | — | WO | claimed |
| US-4952562-A | TREATMENT OF CARDIOVASCULAR DISORDERS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-28 | — | — | US | claimed |
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0494248-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | — | 1992-08-26 | — | — | EP | disclosed |
| EP-0494248-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-07-15 | — | — | EP | disclosed |
| WO-1991004746-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| US-4952562-A | TREATMENT OF CARDIOVASCULAR DISORDERS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |